The Evaluation and Management of Coronary Artery Disease in the Lung Transplant Patient
Lung transplantation can greatly improve quality of life and extend survival in those with end-
stage lung disease. In order to derive the maximal benefit from such a procedure, patients …
stage lung disease. In order to derive the maximal benefit from such a procedure, patients …
A systematic review and meta-analysis of coronary artery disease and revascularization in lung transplant patients
Coronary artery disease (CAD) is common in candidates for lung transplantation (LTx) and
has historically been considered a relative contraindication to transplantation. We look to …
has historically been considered a relative contraindication to transplantation. We look to …
[PDF][PDF] lp-PLA2, RBP 与冠心病病变程度相关性及其疾病诱发的危险因素分析
王正芳， 姜润涵， 吴天学， 徐薇… - Progress in Modern …, 2022 - biomed.cnjournals.com
摘要目的: 研究脂蛋白磷脂酶A2 (lp-PLA2), 视黄醇结合蛋白(RBP) 与冠心病(CAD)
病变程度的相关性及冠心病病变发生的危险因素. 方法: 以2019 年12 月至2021 年12 …
病变程度的相关性及冠心病病变发生的危险因素. 方法: 以2019 年12 月至2021 年12 …
The impact of time from ILD diagnosis to referral to the transplant center on the probability of inclusion in the transplant waiting list
VM Mora-Cuesta, A Martínez-Meñaca… - Heart & Lung, 2024 - Elsevier
Background Lung transplant is a therapeutic option for patients with progressive interstitial
lung disease (ILD). Objectives The objective of this study was to determine whether time …
lung disease (ILD). Objectives The objective of this study was to determine whether time …
Lung transplant survival with past and concomitant cardiac revascularization
T Tran, MA Kashem, A Firoz, R Yanagida… - The Journal of Heart and …, 2023 - Elsevier
Background Coronary artery disease is common among lung transplant (LTx) candidates
and has historically been viewed as a contraindication to the procedure. Survival outcomes …
and has historically been viewed as a contraindication to the procedure. Survival outcomes …